Interview Study Seeks Caregivers of Children/Adolescents with Angelman Syndrome.
The purpose of this interview study is to gather information about caregivers’ experiences with Angelman syndrome (AS). Caregivers of patients aged 5 to 17
The purpose of this interview study is to gather information about caregivers’ experiences with Angelman syndrome (AS). Caregivers of patients aged 5 to 17
Summary by Allyson Berent, DVM, DACVIM Angelman syndrome (AS) is caused by loss of the maternally inherited copy of the UBE3A gene. Like most genes, the UBE3
Summary by Allyson Berent, DVM, DACVIM Individuals affected with Angelman syndrome (AS) are known to have limited functional speech and are typically able to
[wpv-autop]In Partnership With Vivint Gives Back, FAST Announces The Mother Of All Contests.[/wpv-autop][wpv-autop] Starting today, February 1, 2017 and runn
[wpv-autop]Effects of the synthetic neurosteroid ganaxolone on seizure activity and behavioral deficits in an Angelman syndrome mouse model.[/wpv-autop][wpv-
How FAST Is Changing The Landscape Of Angelman Research When you set out to cure an ‘incurable’ genetic disorder, you need three things: a comprehensive,
Read more about the exciting work that has earned the Segal Lab $1.1 Million for research.
Additional Gene Therapy Approach For Angelman Syndrome Explored By Paula Evans The Foundation for Angelman Syndrome Therapeutics (FAST) is delighted to annou
Help Ovid Therapeutics Color Our World Beautiful! An Announcement from Ovid Therapeutics Ovid Therapeutics is working towards initiating its phase II study o
Edwin Weeber, Ph.D. is a Professor in the Department of Molecular Pharmacology and Physiology and the Chief Scientific Officer at the University of South Flo